APEIRON Biologics
Focused on the discovery and development of novel cancer immunotherapies. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€91m (Public information from Jul 2024)
Company register number FN 242223k
Vienna Austria (HQ)
Authorizing premium user...